1. Home
  2. UVV vs OCS Comparison

UVV vs OCS Comparison

Compare UVV & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Corporation

UVV

Universal Corporation

HOLD

Current Price

$52.72

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Oculis Holding AG Ordinary shares

OCS

Oculis Holding AG Ordinary shares

HOLD

Current Price

$24.57

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVV
OCS
Founded
1886
2003
Country
United States
Switzerland
Employees
N/A
3
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
UVV
OCS
Price
$52.72
$24.57
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$42.00
AVG Volume (30 Days)
152.4K
353.4K
Earning Date
02-09-2026
03-03-2026
Dividend Yield
6.23%
N/A
EPS Growth
N/A
N/A
EPS
3.02
N/A
Revenue
$2,922,924,000.00
N/A
Revenue This Year
$0.67
$466.06
Revenue Next Year
$0.10
$502.05
P/E Ratio
$17.44
N/A
Revenue Growth
7.40
N/A
52 Week Low
$49.96
$14.00
52 Week High
$67.33
$30.68

Technical Indicators

Market Signals
Indicator
UVV
OCS
Relative Strength Index (RSI) 49.58 37.93
Support Level $51.79 $19.00
Resistance Level $53.95 $29.19
Average True Range (ATR) 0.85 1.21
MACD 0.08 -0.25
Stochastic Oscillator 65.08 11.59

Price Performance

Historical Comparison
UVV
OCS

About UVV Universal Corporation

Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.

Share on Social Networks: